Family Endures MS and Expense of Fighting It

The U.S. Senate currently is debating legislation that would allow for a regulatory pathway for safe, effective, affordable, and comparable alternatives to biologic drugs. This issue is gaining attention nationwide. A Washington state man tells his family's story of multiple sclerosis, the expense of fighting it, and the need for more affordable versions of biologic drugs for MS and other diseases. Read the complete story here.